Avantor vs BioMarin Pharmaceutical
Avantor (AVTR), health care, and BioMarin Pharmaceutical (BMRN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
BioMarin Pharmaceutical is worth $11.3B on the stock market and Avantor $10.3B: BioMarin Pharmaceutical is valued at 10% more. Avantor's operating margin in its latest fiscal year was -3.76% and BioMarin Pharmaceutical's 12.7%. Over the past year Avantor's share price has moved +37.5% and BioMarin Pharmaceutical's +7.07%.
Key facts
- Avantor market value
- $10.3B
- BioMarin Pharmaceutical market value
- $11.3B
- Avantor P/E
- 30.4
- Avantor revenue
- $6.6BFY to 2025-12-31
- BioMarin Pharmaceutical revenue
- $3.2BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Avantor | BioMarin Pharmaceutical |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $10.3Blower | $11.3Bhigher |
| Revenue | $6.6Bhigher | $3.2Blower |
| Earnings | -$530.2Mlower | $348.9Mhigher |
| Employees | 13,500higher | 3,221lower |
| Total assets | $11.8Bhigher | $7.6Blower |
| Valuation | ||
| P/E | 30.4 | — |
| P/S | 1.6lower | 3.5higher |
| P/B | 1.8lower | 1.8higher |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | -3.76%lower | 12.7%higher |
| Balance sheet | ||
| Net assets | $5.6Blower | $6.1Bhigher |
| Total liabilities | $6.2Bhigher | $1.5Blower |
| Total debt | $3.9B | — |
| Cash on hand | $365.4Mlower | $1.3Bhigher |
| Price change | ||
| Today | -0.91%lower | +0.90%higher |
| 1 year | +37.5%higher | +7.07%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Dodge & Cox team1.0% / 0.5%
Avantor only (8)
- Arnaud Ajdler19.1%
- Edgar Wachenheim4.6%
- Mason Hawkins2.4%
- David Greenspan1.6%
- Steven Romick1.1%
- Stephen Yacktman0.9%
- Chuck Royce (founder)0.5%
- Diamond Hill team0.2%
BioMarin Pharmaceutical only (2)
- Andreas Halvorsen1.2%
- Primecap team0.6%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Avantor / BioMarin Pharmaceutical). Who owns AVTR · Who owns BMRN
More on Avantor
Further comparisons
Avantor against its closest peers
BioMarin Pharmaceutical against its closest peers
Learn
Questions and answers
Which is bigger, Avantor or BioMarin Pharmaceutical?
By market value, BioMarin Pharmaceutical is the larger: $11.3B against $10.3B for Avantor. By revenue in its latest fiscal year, Avantor is the larger: $6.6B against $3.2B for BioMarin Pharmaceutical.
Which has the higher operating margin?
BioMarin Pharmaceutical: 12.7%, against -3.76% for Avantor. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Avantor and BioMarin Pharmaceutical?
In their latest 13F filings, Dodge & Cox team holds both.
Cite this page
Funkfolio, “Avantor vs BioMarin Pharmaceutical”, data as of 17 November 2026. https://funkfolio.com/compare/avtr-vs-bmrn
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.